BIOMAT Database Logo BIOMAT Database Logo

A68930: a potent agonist selective for the dopamine D1 receptor. 1991

M P DeNinno, and R Schoenleber, and R MacKenzie, and D R Britton, and K E Asin, and C Briggs, and J M Trugman, and M Ackerman, and L Artman, and L Bednarz
Neuroscience Research Division, Abbott Laboratories, Abbott Park, IL 60064.

A68930, (1R,3S)-1-aminomethyl-5,6-dihydroxy-3-phenylisochroman HCl, is a potent (EC50 = 2.5 nM), partial (intrinsic activity = 66% of dopamine) agonist in the fish retina dopamine-sensitive adenylate cyclase model of the D1 dopamine receptor. In the rat caudate-putamen model of the D1 dopamine receptor, A68930 is a potent (EC50 = 2.1 nM) full agonist. In contrast, A68930 is a much weaker (EC50 = 3920 nM) full agonist in a biochemical model of the dopamine D2 receptor. The orientation of the 3-phenyl substituent in the molecule is critical for the affinity and selectivity of the molecule towards the dopamine D1 receptor. A68930 also displays weak alpha 2-agonist activity but the molecule is virtually inactive at the alpha 1- and beta-adrenoceptors. When tested in rats bearing a unilateral 6-OHDA lesion of the nigro-neostriatal neurons, A68930 elicits prolonged (greater than 20 h) contralateral turning that is antagonized by dopamine D1 receptor selective doses of SCH 23390 but not by D2 receptor selective doses of haloperidol. In this lesioned rat model, A68930 increases 2-deoxyglucose accumulation in the lesioned substantia nigra, pars reticulata. When tested in normal rats, A68930 elicits hyperactivity and, at higher doses, produces a forelimb clonus.

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D011942 Receptors, Adrenergic, alpha One of the two major pharmacological subdivisions of adrenergic receptors that were originally defined by the relative potencies of various adrenergic compounds. The alpha receptors were initially described as excitatory receptors that post-junctionally stimulate SMOOTH MUSCLE contraction. However, further analysis has revealed a more complex picture involving several alpha receptor subtypes and their involvement in feedback regulation. Adrenergic alpha-Receptor,Adrenergic alpha-Receptors,Receptors, alpha-Adrenergic,alpha-Adrenergic Receptor,alpha-Adrenergic Receptors,Receptor, Adrenergic, alpha,Adrenergic alpha Receptor,Adrenergic alpha Receptors,Receptor, alpha-Adrenergic,Receptors, alpha Adrenergic,alpha Adrenergic Receptor,alpha Adrenergic Receptors,alpha-Receptor, Adrenergic,alpha-Receptors, Adrenergic
D011943 Receptors, Adrenergic, beta One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS. Adrenergic beta-Receptor,Adrenergic beta-Receptors,Receptors, beta-Adrenergic,beta Adrenergic Receptor,beta-Adrenergic Receptor,beta-Adrenergic Receptors,Receptor, Adrenergic, beta,Adrenergic Receptor, beta,Adrenergic beta Receptor,Adrenergic beta Receptors,Receptor, beta Adrenergic,Receptor, beta-Adrenergic,Receptors, beta Adrenergic,beta Adrenergic Receptors,beta-Receptor, Adrenergic,beta-Receptors, Adrenergic
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D002347 Carps Common name for a number of different species of fish in the family Cyprinidae. This includes, among others, the common carp, crucian carp, grass carp, and silver carp. Carassius carassius,Crucian Carp,Cyprinus,Grass Carp,Carp,Ctenopharyngodon idellus,Cyprinus carpio,Hypophthalmichthys molitrix,Koi Carp,Silver Carp,Carp, Crucian,Carp, Grass,Carp, Koi,Carp, Silver,Carps, Crucian,Carps, Grass,Carps, Silver,Crucian Carps,Grass Carps,Silver Carps
D002839 Chromans Benzopyrans saturated in the 2 and 3 positions. Dihydrobenzopyrans
D003847 Deoxyglucose 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity. 2-Deoxy-D-glucose,2-Deoxyglucose,2-Desoxy-D-glucose,2 Deoxy D glucose,2 Deoxyglucose,2 Desoxy D glucose
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol

Related Publications

M P DeNinno, and R Schoenleber, and R MacKenzie, and D R Britton, and K E Asin, and C Briggs, and J M Trugman, and M Ackerman, and L Artman, and L Bednarz
Rapid reversal of denervation supersensitivity of dopamine D1 receptors by l-dopa or a novel dopamine D1 receptor agonist, A68930.
July 1991, European journal of pharmacology,
M P DeNinno, and R Schoenleber, and R MacKenzie, and D R Britton, and K E Asin, and C Briggs, and J M Trugman, and M Ackerman, and L Artman, and L Bednarz
Dopamine D1 receptor agonist A68930 attenuates acute kidney injury by inhibiting NLRP3 inflammasome activation.
July 2020, Journal of pharmacological sciences,
M P DeNinno, and R Schoenleber, and R MacKenzie, and D R Britton, and K E Asin, and C Briggs, and J M Trugman, and M Ackerman, and L Artman, and L Bednarz
Dihydrexidine: a new potent peripheral dopamine D1 receptor agonist.
April 1993, European journal of pharmacology,
M P DeNinno, and R Schoenleber, and R MacKenzie, and D R Britton, and K E Asin, and C Briggs, and J M Trugman, and M Ackerman, and L Artman, and L Bednarz
The selective dopamine D1 receptor agonist SKF81297 modulates NMDA receptor currents independently of D1 receptors.
April 2022, Neuropharmacology,
M P DeNinno, and R Schoenleber, and R MacKenzie, and D R Britton, and K E Asin, and C Briggs, and J M Trugman, and M Ackerman, and L Artman, and L Bednarz
A68930 is a potent, full agonist at dopamine1 (D1) receptors in renal epithelial LLC-PK1 cells.
June 1992, British journal of pharmacology,
M P DeNinno, and R Schoenleber, and R MacKenzie, and D R Britton, and K E Asin, and C Briggs, and J M Trugman, and M Ackerman, and L Artman, and L Bednarz
A D1/D2 chimeric dopamine receptor mediates a D1 response to a D2-selective agonist.
May 1993, FEBS letters,
M P DeNinno, and R Schoenleber, and R MacKenzie, and D R Britton, and K E Asin, and C Briggs, and J M Trugman, and M Ackerman, and L Artman, and L Bednarz
The potent and selective dopamine D1 receptor agonist A-77636 increases cortical and hippocampal acetylcholine release in the rat.
July 1994, European journal of pharmacology,
M P DeNinno, and R Schoenleber, and R MacKenzie, and D R Britton, and K E Asin, and C Briggs, and J M Trugman, and M Ackerman, and L Artman, and L Bednarz
The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors.
June 2001, Psychopharmacology,
M P DeNinno, and R Schoenleber, and R MacKenzie, and D R Britton, and K E Asin, and C Briggs, and J M Trugman, and M Ackerman, and L Artman, and L Bednarz
FPL 63012AR: a potent D1-receptor agonist.
June 1990, British journal of pharmacology,
M P DeNinno, and R Schoenleber, and R MacKenzie, and D R Britton, and K E Asin, and C Briggs, and J M Trugman, and M Ackerman, and L Artman, and L Bednarz
trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist.
June 1990, Journal of medicinal chemistry,
Copied contents to your clipboard!